Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Eton Pharmaceuticals, Inc.

NASDAQ: ETON · Life Sciences · 10 alerts · CIK 1710340

Eton Pharmaceuticals, Inc. stories on ALFA USA NewsRead the news →
Share price
$63.88Close, Nov 16
Market cap
$1.84B
Shares outstanding
28.84MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Eton Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:46 PM ET Form 4
Insider Selling

Eton Pharmaceuticals Chief Commercial Officer Ipek Erdogan-Trinkaus Sells $236K of Stock

Ipek Erdogan-Trinkaus, Chief Commercial Officer, sold 3,500 shares of Eton Pharmaceuticals, Inc. at $67.18 to $67.88 a share (average $67.41) in 2 transactions, worth $236K in total on Nov 10, 2026. Shares held after the trade: 4,081 (-22.1%).

Value
$236K
Shares
3,500
Average price
$67.41
Role
Chief Commercial Officer
Holding change
-22.1%
Trade date
Nov 10, 2026
6:22 PM ET Form 4
Insider Selling

Eton Pharmaceuticals Insider Charles J. Casamento Sells $5.35M of Stock

Charles J. Casamento sold 80,555 shares of Eton Pharmaceuticals, Inc. at $64.33 to $67.87 a share (average $66.35) in 5 transactions, worth $5.35M in total on Nov 10, 2026. Shares held after the trade: 0 (-100.0%).

Value
$5.35M
Shares
80,555
Average price
$66.35
Holding change
-100.0%
Trade date
Nov 10, 2026
4:49 PM ET Form 4
Insider Selling

Eton Pharmaceuticals Chief Business Officer David Krempa Sells $229K of Stock

David Krempa, Chief Business Officer, sold 4,166 shares of Eton Pharmaceuticals, Inc. at $55.07 a share, worth $229K in total on Oct 6, 2026. Shares held after the trade: 43,381 (-8.8%).

Value
$229K
Shares
4,166
Price
$55.07
Role
Chief Business Officer
Holding change
-8.8%
Trade date
Oct 6, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.